MicroStrategy
MSTR
特斯拉
TSLA
MARA Holdings
MARA
Coinbase
COIN
亚马逊
AMZN
美股市场个股详情
NAMS NewAmsterdam Pharma
- 25.950
- +0.320+1.25%
收盘价 12/24 13:00 (美东)
- 26.530
- +0.580+2.24%
盘后 15:41 (美东)
27.12亿总市值-11.74市盈率TTM
26.000最高价25.230最低价17.00万股成交量25.610今开25.630昨收437.47万成交额0.38%换手率亏损市盈率(静)1.05亿总股本27.29052周最高7.16市净率11.69亿流通值11.18052周最低--股息TTM4506.01万流通股32.880历史最高--股息率TTM3.00%振幅5.633历史最低25.728平均价1股每手
关于NewAmsterdam Pharma公司
NewAmsterdam Pharma Co NV 是一家处于后研发阶段的生物制药公司，其使命是改善代谢性疾病患者的护理，这些疾病目前批准的疗法尚未充分或耐受性良好。其产品 obicetrapib 是下一代口服低剂量 CETP 抑制剂，为了克服当前 LDL-C 降低治疗的局限性。
公司介绍
公司代码NAMS
公司名称NewAmsterdam Pharma
上市日期2021/02/08
成立日期2022
CEODr. Michael Harvey Davidson, M.D.
所属市场纳斯达克
员工数量29
年结日12-31
公司地址Gooimeer 2-35
城市Naarden
省份北荷兰省
国家荷兰
邮编1411 DC
电话31-35-206-29-71
董事高管
- 姓名
- 职务
- 年薪
- Dr. Michael Harvey Davidson, M.D.
- Chief Executive Officer and Director
- 580.56万
- Juliette Audet
- Chief Business Officer
- 4.56万
- William B.J. Jones, Jr
- Chief Commercial Officer
- --
- Ian Somaiya
- Chief Financial Officer
- 355.31万
- Douglas F. Kling
- Chief Operating Officer
- --
- Dr. Johannes Jacob Pieter Kastelein, M.D.
- Chief Scientific Officer and Director
- 297.86万
- Louise Kooij
- Chief Accounting Officer
- --
- William H. Lewis, J.D.,M.B.A.
- Chairman of the Board
- --
- Willian H Lewis
- Lead Independent Chairman of the Board
- --
- Mark C. McKenna
- Independent Director
- --
- Louis G. Lange, M.D.
- Independent Director
- 33.91万
- Dr. James N. Topper, M.D.,PhD
- Independent Director
- 4.00万
- Wouter Joustra
- Independent Director
- --
- Janneke van der Kamp
- Independent Director
- 13.47万
- John W. Smither
- Independent Director
- 13.88万
- Dr. Nicholas S. Downing, M.D.
- Independent Director
- 4.73万